Phosphatases which activate map kinase pathways

Details Phosphatases which activate map kinase pathways Phosphatases which activate map kinase pathways

2005-05-31

2005-05-31

Nashed, Nashaat T. (Department: 1652)

Chemistry: molecular biology and microbiology

Enzyme , proenzyme; compositions thereof; process for...

Hydrolase

C435S195000, C435S252330, C435S254110, C435S325000, C435S320100, C435S091500, C435S023000, C435S023000

Reexamination Certificate

active

06900043

ABSTRACT:
The present invention provides novel JNK activating phosphatase polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing JNK activating phosphatase polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with JNK activating phosphatase polypeptides.

REFERENCES:
patent: 4179337 (1979-12-01), Davis et al.
patent: 4376110 (1983-03-01), David et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4945050 (1990-07-01), Sanford et al.
patent: 4970154 (1990-11-01), Chang
patent: 5234784 (1993-08-01), Aslam et al.
patent: 5364791 (1994-11-01), Vegeto et al.
patent: 5399346 (1995-03-01), Anderson et al.
patent: 5459036 (1995-10-01), Lechner et al.
patent: 5489743 (1996-02-01), Robinson et al.
patent: 5557032 (1996-09-01), Mak
patent: 5589362 (1996-12-01), Bujard et al.
patent: 5593875 (1997-01-01), Wurm et al.
patent: 5631236 (1997-05-01), Woo et al.
patent: 5635399 (1997-06-01), Kriegler et al.
patent: 5650298 (1997-07-01), Bujard et al.
patent: 5654168 (1997-08-01), Bujard et al.
patent: 5663314 (1997-09-01), Seger et al.
patent: 5672344 (1997-09-01), Kelley et al.
patent: 5672510 (1997-09-01), Eglitis et al.
patent: 5676954 (1997-10-01), Brigham
patent: 5679559 (1997-10-01), Kim et al.
patent: 404384 (1990-12-01), None
patent: WO 91/09955 (1991-07-01), None
patent: WO 94/28122 (1994-12-01), None
patent: WO 95/24670 (1995-12-01), None
patent: WO 96/37609 (1996-11-01), None
patent: WO 96/40958 (1996-12-01), None
patent: WO 96/41865 (1996-12-01), None
patent: WO 97/00315 (1997-01-01), None
patent: WO 97/16442 (1997-05-01), None
patent: WO 97/31899 (1997-09-01), None
Blackshear, et al., “Brca1 and Brca2 expression in mitotic and meiotic cells of mice,”Oncogene, vol. 16, pp. 61-68 (1998), U.S.
Lähdevirta et al., “Elevated Levels of Circulating Cachectin/Tumor Necrosis Factor in Patients with Acquired Immunodeficiency Syndrome”Am. J. Med., vol. 85, pp. 289-291 (1988).
Leder et al., “Consequences of Widespread Deregulation of the c-myc Gene in Transgenic Mice: Multiple Neoplasms and Normal Development”Cell, vol. 45, pp. 485-495 (1986).
Lucklow et al., “Efficient Generation of Infectious Recombinant Baculoviruses by Site-Specific Transposon-Mediated Insertion of Foreign Genes into a Baculovirus Genome Propagated inEscherichia coli”J. Virology., vol. 67, pp. 4566-4579 (1993).
Labastie et al., “Molecular Identity of Hermatopoietic Precursor Cells Emerging in the Human Embryo”Blood, vol. 92, pp. 3624-3635 (1998).
M.H. Cobb et al., “How MAP Kinases Are Regulated”J. Biol. Chem., vol. 270, pp. 14843-14846 (1995).
Liu, et al., “Cytokine-induced neutrophil chemottractant mRNA expressed in cerebral ischemia,”Neuroscience Letters, vol. 164, pp. 125-128 (1993).
Liu, et al., “Tumor Necrosis Factor-α Expression in Ischemic Neurons,”Stroke, vol. 25, No. 7, pp. 1481-1488 (1994).
Marks, et al., “By-passing Immunization: Human Antibodies from V-gene Libraries Displayed on Phage”J. Mol. Biol., vol. 222, pp. 581-597 (1991).
Fiona, et al., “[20] Solubilization of Protein Aggregates”Methods in Enzymology, vol. 182, pp. 264-276 (1990).
Mason et al., “The Hypogonadal Mouse: Reproductive Functions Restored by Gene Therapy”Science, vol. 234, pp. 1372-1378 (1986).
Merrifield, R.B., “Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide”J. Am. Chem. Soc., vol. 85, pp. 2149-2154(1963)
Magram et al., “Development regulation of a cloned adult β-globin gene in transgenic mice”Nature, vol. 315, pp. 338-340 (1985).
Morrison, et al., “Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains”Proc. Natl. Acad. Sci., U.S.A., vol. 81, pp. 6851-6855 (1984).
Nemoto et al., “Opposing Effects of Jun Kinase and p38 Mitogen-Activated Protein Kinases on Cardiomyocyte Hypertrophy”Mol. Cell. Biol., vol. 18(6), pp. 3518-3526 (1998).
Ornitz et al., “Elastase I Promoter Directs Expression of Human Growth Hormone and SV40 T Antigen Genes to Pancreatic Acinar Cells in Transgenic Mice”Cold Spring Harbor Symp. Quant. Biol., vol. 50, pp. 399-409 (1986).
Pinkert et al., “An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice”Genes and Devel., vol. 1, pp. 268-276 (1987).
Jurecic et al., “Identification and Cloning of Differentially Expressed Genes by Long-Distance Differential Display”Anal. Biochem., vol. 259, pp. 235-244 (1998).
Ramirez et al., “The MEKK-JNK Pathway Is Stimulated by α-Adrenergic Receptor and Ras Activation and Is Associated with in Vitro and in Vivo Cardiac Hypertrophy”J. Biol. Chem., vol. 272 No. 22, pp. 14057-14061 (1997).
Readhead et al., “Expression of a Myelin Basic Protein Gene in Transgenic Shiverer Mice: Correction of the Dysmyelinating Phenotype”Cell, vol. 48, pp. 703-712 (1987).
Riechmann, et al., “Reshaping human antibodies for therapy”Nature, vol. 332, pp. 323-327 (1988).
Shani, “Tissue-specific expression of rat myosin light-chain 2 gene in transgenic mice”Nature, vol. 314, pp. 283-286 (1985).
Shohami et al., “Closed Head Injury Triggers Early Production of TNFα and IL-6 by Brain Tissue”J. Cereb. Blood Flow Metab., vol. 14, pp. 615-619 (1994).
Silberbach et al., “Extracellular Signal-regular Protein Kinase Activation Is Required for the Anti-hypertrophic Effect of Atrial Natriuretic Factor in Neonatal Rat Ventricular Myocytes”J. Biol. Chem., vol. 274, No. 35, pp. 24858-24864 (1999).
Swift et al., “Tissue-Specific Expression of the Rat Pancreatic Elastase I Gene in Transgenic Mice”Cell, vol. 38, pp. 639-646 (1984).
Jaffredo et al., “Intraaortic hemopoietic cells are derived from endothelial cells during ontogeny”Development, vol. 125, pp. 4575-4583 (1998).
Thomas et al., “Site-Directed Mutagenesis by Gene Targeting in Mouse Embryo-Derived Stem Cells”Cell, vol. 51, pp. 503-512 (1987).
Thomas et al., “High Frequency Targeting of Genes to Specific Sites in the Mammalian Genome”Cell, vol. 44, pp. 419-428 (1986).
Verhoeyen et al., “Reshaping Human Antibodies: Grafting an Antilysozyme Activity”Science, vol. 239, pp. 1534-1536 (1988).
Villa-Kamaroff et al., “A bacterial clone synthesizing proinsulin”Proc. Natl. Acad. Sci. U.S.A., vol. 75, pp. 3727-3731 (1978).
W. Nürnberg, et al., “DIG-Labeled RNA In Situ Hybridization Without Coverslipping,”Biotechniques, vol. 18, pp. 406-410 (1995).
Wagner et al., “Nucleotide sequence of the thymidine kinase gene of herpes simplex virus type 1”Proc. Natl. Acad. Sci. U.S.A., vol. 78, pp. 1441-1445 (1981).
Wang et al., “Cardiac Hypertrophy Induced by Mitogen-activated Protein Kinase Kinase 7, a Specific Activator for c-Jun NH2-terminal Kinase in Ventricular Muscle Cells”J. Biol. Chem., vol. 273, No. 10, pp. 5423-5426 (1998).
Ip et al., “Signal transduction by the c-Jun N-terminal kinase (JNK)—from inflammation to development”Curr. Opin. Cell Biol., vol. 10, pp. 205-219 (1998).
Yamamoto, et al., “Identification of a Functional Promoter in the Long Terminal Repeat of Rous Sarcoma Virus,”Cell, vol. 22, pp. 787-797 (1980).
Yano et al., “Differential Activation of Cardiac c-Jun Amino-Terminal Kinase and Extracellular Signal-Regulated Kinase in Angiotensin II-Mediated Hypertension”Circ. Res., vol. 83, No. 7, pp. 752-760 (1998).
Jurecic, et al., “Differential mRNA display using anchored oligo-dT and long sequence-specific primers as arbitrary primers,”TIG, vol. 12, No. 12, pp. 502-504 (1996).
“Gene Expression Technology,”Methods in Enzymology, D. Goeddel (Ed.)

Affiliated with

Also associated with

Rating

Phosphatases which activate map kinase pathways does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phosphatases which activate map kinase pathways, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphatases which activate map kinase pathways will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3443667